Drug profile · INN
benzydamine
DIFFLAM
benzydamine (DIFFLAM) is a cyclooxygenase inhibitor. Associated with Lacuna Pharma Pty Ltd.
TGA: approved
Patents linked 1
Pipeline programs 0
News articles 0
Drug details — benzydamine
- Class
- —
- Route
- —
- Patents
- 1
- Programs
- 0
- Data quality
- 0.81
Quick answer
benzydamine (DIFFLAM) is a cyclooxygenase inhibitor. Associated with Lacuna Pharma Pty Ltd.
Key facts
INN benzydamine
Brand DIFFLAM
Mechanism Cyclooxygenase inhibitor
Target Cyclooxygenase
Originator Lacuna Pharma Pty Ltd
Mechanism of action
Cyclooxygenase inhibitor
Primary target: Cyclooxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Related & competitor drugs
Related patents
Frequently asked questions
What is benzydamine?
benzydamine (DIFFLAM) is a cyclooxygenase inhibitor. Associated with Lacuna Pharma Pty Ltd.
What is the brand name for benzydamine?
DIFFLAM is a marketed brand name for benzydamine. Check FDA Drugs@FDA for the current US label holder and prescribing information.